Treanda (bendamustine HCL): Recall - Particulate Matter in Vial

January 30, 2012, 8:50 am by Safety Alerts

Potential adverse events after intravenous administration of solutions containing particulates may include emboli and result in disruption of blood flow, causing tissue/organ damage.

Read the full article

More from Safety Alerts

Zithromax (azithromycin): FDA Statement on risk of cardiovascular death
Safety Alerts : May 17, 2012, 2:45 am
A retrospective cohort study reports small increase in risk of cardiovascular deaths and risk of all cause deaths associated with 5 day course of antibiotic drug

Hydromorphone Hydrochloride Injection 1 MG/ML, (C-II) 1 ML Fill In 2.5 ML Carpuject: Recall - May Contain More Than the Intended Fill Volume
Safety Alerts : May 14, 2012, 1:05 am
An overdose of Hydromorphone may result in life-threatening consequences, including respiratory depression (slowed breathing or suspension of breathing), low blood pressure, and reduced heart rate including circulatory collapse.

X-Rock: Recall - Undeclared Drug Ingredient
Safety Alerts : April 25, 2012, 8:50 am
Undeclared active ingredients may interact with nitrates found in some prescription drugs (such as nitroglycerin) and lower blood pressure to dangerous levels.

Roche Diagnostics Operations Elecsys Troponin I and Elecsys Troponin I STAT Immunoassays: Recall – Doctors may receive a falsely low result
Safety Alerts : April 24, 2012, 12:15 pm
Customers should immediately discontinue use of any affected product.

Certain Compounded Drugs from Franck's: FDA Issues Second Warning to Physicians
Safety Alerts : April 20, 2012, 12:25 pm
FDA received reports of eye infections in patients who were given injections of drug products containing triamcinolone during eye surgery.